Wireless Powered Closed Loop Neuromodulation
INOPASE
EXPLORING A NEW WAY OF TREATING CHRONIC NEUROLOGICAL DISEASES
THROUGH PERSONALIZED CLOSED-LOOP NEUROMODULATION
INOPASE empowers and supports people with chronic neurological diseases
to improve their quality of life
OUR CLOSED-LOOP NEUROMODULATION
Closed-loop neuromodulation is the key to restoring lost function by inducing neuroplasticity in the brain.
Our closed-loop neuromodulation has advanced algorithm to detect symptoms and provide dynamic stimulation therapy.
This innovative technology enables personalized treatment based on biological sensing, unlocking the full potential of your mind and body.
PROJECTS
An integrated solution that promises to revolutionize the way we diagnose and treat challenging diseases.
Closed-Loop
Sacral Neuromodulation
Imagine a breakthrough solution that could ease the burden on those struggling with overactive bladder, while increasing the chances of achieving long-awaited relief.
With the latest advancements in medical research, we can now offer a path to overactive bladder remission that is both effective and compassionate, helping patients take back control of their lives and achieve the freedom they deserve.
Closed-Loop
Brain Neuromodulation
Imagine a cutting-edge device that has the power to unlock new possibilities for those struggling with drug-resistant, intractable epilepsy.
By combining the latest advancements in technology with the insights of leading clinical experts, we are developing an integrated solution that promises to revolutionize the way we diagnose and treat this challenging condition.
MEET THE TEAM
MUNEMASA SUGIMOTO
Founder & CEO
• 10 years+ business experiences in healthcare industry (Novartis, CDI Medical)
• Project Assistant Professor at the University of Tokyo Hospital
• Japan BIODESIGN Innovation Fellow
• CPA experience (KPMG AZSA LLC.)
• MBA at Washington University in St. Louis, US
WANG YEN PO
Founder & CTO
• 8 years+ experiences in wireless power and closed-loop stimulation development
• Ph.D student in Human Engineer at the University of Tokyo
• Japan BIODESIGN Innovation Fellow
• Fellowship at Innovation for Intelligent World
• BE Health Ventures, Japan PJ Lead
KUMI SAKURAI
CMO
• 15 years+ business and marketing experiences in medical device industry (Medtronic, Abbott, Danaher Corporation)
• Premo Partners, Inc., CEO
• Research Fellow at Keio univ. hospital
• MBA at Kanazawa Institute of Technology, Japan. Master at Waseda University, Japan
PARTNERS
Japan agency for medical research
and development
Tokyo Metropolitan
Small & Medium Entreprise Support Center
Japan External
Trade Organization
B.E.
Accelerator
C.P. Medical
COFORCE Medical Inc.
LINK Medical Research
Tohoku University Hospital
Industrial Technology Research Institute
Tokyo Institute of Technology
The University of Tokyo
Yokohama City University
Fukushima Medical University
Dokkyo Medical University
Nagano Prefectural
Shinshu Medical Center
Marien Hospital
HerneUniversitätsklinikum der Ruhr-Universität Bochum
NEWS
2023.02.28
INOPASE obtained a Medical Device Manufacturing License
2023.02.28
INOPASE participated in the middleweight division of “GET IN THE RING OSAKA 2023 – Health Tech”
2023.02.28
INOPASE will participate in the 3rd Japan Biodesign Conference on March 3, 2023 (as a speaker and booth exhibitor)
2023.01.30
INOPASE will participate in JETRO Online Joint Company Information Session Winter 2023
2022.12.16 - 18
Wang Yen Po, CTO of INOPASE, has been selected for the 2022 Global to Outstanding Leadership Award in Healthcare and will attend the award ceremony at the Health 2.0 Conference (Dubai)
2022.10.26 - 27
INOPASE will participate in ASIAN ENTREPRENEURSHIP AWARD 2022 (AEA 2022)
2022.10.12 - 14
INOPASE will participate in Japan Healthcare Venture Summit 2022 (Pacifico Yokohama)
INOPASE was selected for the 2022 Foreign Patent Application Fee Subsidy Program
2022.09.28
INOPASE has been selected for the X-HUB TOKYO Outbound Program Germany Course (JETRO)
2022.09.28
INOPASE will participate in Japan Analytical & Scientific Instruments Show, JASIS 2022 (Makuhari Messe International Exhibition Hall)
2022.06.08
INOPASE obtained funding from Japan Agency for Medical Research and Development (AMED)
2021.11.16
INOPASE features on Business NEXT media in Taiwan, the Taiwan’s most influential technology and financial media
2021.11.16
INOPASE obtained grant from Japan Tokyo Government
2021.09.01
INOPASE won the Second winner in global competition at BME iDEA APAC 2021 Annual Summit
2021.08.16
INOPASE’s solution is being introduced by Taiwanese Urologist doctor
2021.08.16
INOPASE features on Yahoo Finance News: Witness 12 MedTech Startups Show the Latest Innovation of Healthcare
2021.06.24
INOPASE obtained funding from Japan Agency for Medical Research and Development (AMED)